Pharming Group excels with RUCONEST and JOENJA, showing strong revenue growth and positive cash flow. Check out my recommendation for PHAR stock.

Optinose (NASDAQ: OPTN) has announced its financial results for the year and quarter ending December 31, 2024, spotlighting ...

TriSalus Life Sciences reports Q4 2024 growth with 59% annual revenue rise and strategic PEDD focus. Discover their path to 2025 EBITDA positivity.

“The company is capable of driving low-double-digit revenue growth annually over the next five years, with even better earnings growth.” Part of this positive outlook comes from the firm’s ...

shares dropped Tuesday after the company warned it could see soft subscriber growth after a "challenging" quarter. New subscribers this quarter “are probably going to be soft,” Chief Revenue ...

Ben McPoland highlights a pair of lesser-known growth stocks from the restaurant ... Last year, Sweetgreen’s revenue increased 16% to $676.8m, with comparable store sales up 6%.

JOHANNESBURG, March 11 (Reuters) - South African lender Absa (ABGJ.J), opens new tab forecast mid-single digit revenue growth for 2025 and fewer bad loans following a 10% jump in its annual profit ...

It was the Gilded Age, a time of rapid population growth and transformation from ... order calling for the creation of the External Revenue Service to “collect tariffs, duties, and other foreign ...

Strategic initiatives continue to deliver strong performance with Healthcare & UAE revenue growth of 84.5% & 85.1%, respectively. Net profit declined by SAR 12.7 million, despite the increase in the ...

Oracle on Monday forecasts that strong demand for its artificial intelligence servers will help boost revenue 15% to $66 billion in the fiscal year that begins in June, compared to 7% growth on ...